Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Blog

How to Prevent Colorectal Cancer

healthy living for men featured image

Colorectal cancer remains one of the most common yet preventable forms of cancer worldwide. With advances in screening technology, lifestyle interventions, and early detection methods, we now have more tools than ever to prevent this disease or catch it at its earliest, most treatable stages. In this guide, we'll explore the latest prevention strategies, screening options including innovative blood tests, and answer common questions about colorectal cancer prevention.

Understanding Colorectal Cancer

Before diving into prevention strategies, it's important to understand what colorectal cancer is. Colorectal cancer begins in the colon or rectum, parts of the large intestine. It typically starts as small, noncancerous polyps found on the inner lining of the colon or rectum which have the potential to develop into cancer.

Related: What is Colorectal Cancer? 

Colorectal cancer often develops slowly over the course of years rather than weeks or months, which makes it particularly amenable to prevention strategies and early detection through regular screening.

Is Colorectal Cancer Preventable?

One of the most encouraging aspects of colorectal cancer is that it is largely preventable. Research suggests that as many as 60% of deaths from colorectal cancer are preventable with regular screening and lifestyle modifications. This makes it one of the most preventable forms of cancer.

Prevention falls into two main categories:

  1. Primary prevention: Lifestyle and dietary choices that reduce your risk of developing colorectal cancer
  2. Secondary prevention: Screening tests that find precancerous polyps or detect cancer in its earliest stages

Both approaches are crucial components of a comprehensive prevention strategy.

How to Prevent Colorectal Cancer: Lifestyle Factors

The following lifestyle modifications can play an important role in colorectal cancer prevention. These are provided as general advice; make sure to consult with your practitioner to ensure that your personal lifestyle strategy is the best fit for your individual circumstances.

Dietary Modifications

Diet is a significant contributor to colorectal cancer risk. Certain dietary patterns can either increase or decrease your risk.

  • Increase fiber intake: Consume more fruits, vegetables, whole grains, and legumes. Fiber reduces potential exposure to carcinogens by helping move waste through the digestive tract faster.
  • Limit red and processed meats: Studies show a connection between these foods and increased colorectal cancer risk.
  • Include garlic in your diet: Some studies suggest garlic may have protective effects.
  • Consider Mediterranean diet principles: This eating pattern is associated with lower colorectal cancer risk.
  • Stay hydrated: Drinking plenty of water supports digestive health.

Physical Activity

Regular physical activity is strongly correlated with reduced colorectal cancer risk. Aim for at least 150 minutes of moderate activity or 75 minutes of vigorous activity per week. This doesn't necessarily mean formal exercise—walking, gardening, dancing, or any activity that you enjoy and gets you moving counts!

two people exercising

Exercise helps with colorectal cancer prevention in several ways:

  • Reducing inflammation
  • Enhancing immune function
  • Helping maintain a healthy weight
  • Improving insulin sensitivity
  • Reducing the time potentially harmful substances stay in the colon

Additional Lifestyle Factors

  • Maintain a healthy weight: Obesity is a significant risk factor for colorectal cancer.
  • Limit alcohol consumption: If you drink alcohol, do so in moderation (no more than one drink per day for women and two for men).
  • Don't smoke: Smoking is linked to an increased risk of colorectal cancer.
  • Manage stress: While the direct link to colorectal cancer isn't clear, chronic stress can affect overall health and potentially influence cancer risk.

Managing Chronic Conditions

Some chronic conditions may increase colorectal cancer risk:

  • Inflammatory bowel diseases like Crohn's disease or ulcerative colitis
  • Type 2 diabetes
  • Metabolic syndrome

Working with your practitioner to manage these conditions effectively can help reduce your colorectal cancer risk.

Related: Cancer Prevention Checklist 

Colorectal Cancer Screening: The Cornerstone of Prevention

Screening is perhaps the most powerful tool we have for preventing colorectal cancer deaths. Screening tests can detect precancerous polyps before they develop into cancer, allowing for their removal before cancer even begins. They can also find cancer at an early stage when treatment is most effective.

When to Begin Screening

In the past, screening was recommended starting at age 50. However, colorectal cancer is on the rise, and current guidelines recommend that people at average risk begin colorectal cancer screening at age 45. However, if you have certain risk factors you may need to start screening earlier or screen more frequently. These include:

  • Past history of colorectal polyps or colorectal cancer
  • Family history of colorectal cancer or certain inherited syndromes
  • History of inflammatory bowel disease
  • Personal history of radiation to the abdomen or pelvis

Always consult with your practitioner about when you should begin screening based on your individual risk factors.

Traditional Screening Methods

Several effective screening methods are available:

Colonoscopy: Considered the gold standard, a colonoscopy allows practitioners to view the entire colon and rectum using a flexible tube with a camera. This screening method can detect and remove polyps in the same procedure. If no abnormalities are found, it's typically repeated every 10 years for average-risk individuals.

Flexible Sigmoidoscopy: Similar to colonoscopy but examines only the lower third of the colon. It's usually done every 5 years.

CT Colonography (Virtual Colonoscopy): Uses CT scanning to create detailed images of the colon. If polyps are detected, a follow-up colonoscopy is needed for removal.

Stool-Based Tests: These include:

  • Fecal immunochemical test (FIT): Detects blood in the stool, performed annually
  • Guaiac-based fecal occult blood test (gFOBT): Also detects blood in the stool, performed annually
  • Stool DNA test: Looks for altered DNA and blood in the stool, typically done every three years

Blood Test for Colorectal Cancer: The New Frontier

One of the most exciting developments in colorectal cancer screening is the emergence of blood-based tests. These minimally invasive tests can detect signs of colorectal cancer in a simple blood sample, potentially increasing screening rates among people reluctant to undergo more invasive procedures.

How a Blood Tests for Colorectal Cancer Screening Works

A blood test for colorectal cancer detection typically look for one or more of these biomarkers:

  1. Circulating tumor DNA (ctDNA): Small fragments of DNA released from tumor cells into the bloodstream
  2. Methylated DNA: Abnormal patterns of DNA methylation associated with cancer
  3. Protein biomarkers: Proteins in the blood that may indicate the presence of cancer
  4. Circulating tumor cells (CTCs): Intact cancer cells that have entered the bloodstream

Advantages of Blood-Based Testing

A blood test for colorectal cancer screening offers several advantages:

  • Convenience and simplicity: Only requires a blood draw, which can be done during routine medical visits
  • Increased compliance: May appeal to those who avoid colonoscopy due to its invasive nature
  • Repeat testing: Can be performed more frequently with minimal burden on the patient
  • Early detection: Some blood tests can detect cancer at very early stages
  • Accessibility: Particularly valuable for underserved populations with limited access to traditional screening methods

Current Blood Tests for Colorectal Cancer Screening

Several blood-based tests for colorectal cancer are currently available or in development:

Onco-D-Clare test: This innovative test looks at PBMCs and picks up on changes in the expression profile of these healthy cells. in the bloodstream, potentially identifying colorectal cancer at its earliest stages. The test looks for specific molecular patterns associated with cancer cells.

Methylated SEPT9 DNA test: Detects methylation patterns in the SEPT9 gene, which are associated with colorectal cancer.

Multianalyte blood tests: These analyze multiple biomarkers simultaneously to provide a more comprehensive screening approach.

It's important to note that while blood tests represent a promising advancement in colorectal cancer screening, they currently complement rather than replace traditional screening methods like colonoscopy. A positive blood test typically requires follow-up with a colonoscopy for confirmation and potential polyp removal. Colorectal cancer screening blood tests are a less-invasive first step to understanding personal risk as well as provide information to guide personalized treatment approaches should cancer be detected.

Integrated Approach to Colorectal Cancer Prevention

The most effective approach to colorectal cancer prevention combines:

  1. Regular screening appropriate for your age and risk factors
  2. Healthy lifestyle choices including diet, physical activity, and avoiding tobacco
  3. Management of risk factors like inflammatory bowel disease or family history
  4. Awareness of symptoms that could indicate colorectal cancer

By holistically addressing all these elements, you have the power to significantly reduce your risk of developing colorectal cancer or catch it at its earliest and most treatable stages.

Special Considerations for High-Risk Individuals

People with certain risk factors may need more intensive prevention strategies:

Hereditary Syndromes

Individuals with hereditary conditions like Lynch syndrome or familial adenomatous polyposis (FAP) have a significantly higher risk of developing colorectal cancer. These individuals typically need:

  • Earlier screening (often beginning in their 20s)
  • More frequent screening
  • Consideration of preventive medications or surgical options
  • Genetic counseling for family members

Family History

If you have a first-degree relative who had colorectal cancer, your risk is higher than average. In this case:

  • Begin screening at age 40 or 10 years before the age at which your relative was diagnosed, whichever is earlier
  • Consider more frequent screening
  • Be particularly vigilant about lifestyle prevention strategies

Inflammatory Bowel Disease

If you have Crohn's disease or ulcerative colitis, you are at an increased risk of colorectal cancer, particularly if you've had the condition for many years. You may need:

  • More frequent colonoscopies with multiple biopsies
  • Careful management of their inflammatory bowel disease
  • Consideration of preventive medications

FAQ: Common Questions About Colorectal Cancer

What is the survival rate for colon cancer for 10 years?

Survival rates vary widely depending on the stage at diagnosis:

  • For localized colon cancer (confined to the colon), the 10-year survival rate is approximately 70-75%
  • For regional colon cancer (spread to nearby structures or lymph nodes), the 10-year survival rate is about 50-60%
  • For distant colon cancer (metastasized to distant organs), the 10-year survival rate is approximately 10-15%

These statistics highlight the critical importance of early detection through regular screening. When caught at the earliest stage, colorectal cancer is highly treatable and often curable.

What are the 5 warning signs of bowel cancer?

Watch for these potential warning signs of colorectal cancer:

  1. Changes in bowel habits: Persistent diarrhea, constipation, or narrowing of your stool
  2. Rectal bleeding or blood in the stool: Bright red or very dark blood in the stool
  3. Persistent abdominal discomfort: Cramps, gas, pain, or feeling that the bowel doesn't empty completely
  4. Weakness or fatigue: Can be caused by anemia due to bleeding from the tumor
  5. Unexplained weight loss: Losing weight without trying

It's important to note that these symptoms can be caused by other conditions, such as irritable bowel syndrome, hemorrhoids, or inflammatory bowel disease. However, if you experience any of these symptoms, especially if they persist, consult with your practitioner promptly.

How do you prevent colon cancer?

As discussed throughout this article, preventing colon cancer involves several key strategies:

  1. Regular screening: Follow recommended guidelines for your age and risk level.
  2. Healthy diet: Emphasize fruits, vegetables, whole grains, and limit red and processed meats.
  3. Regular physical activity: Shoot for at least 150 minutes of moderate activity weekly.
  4. Maintain a healthy weight: Particularly important to avoid excess abdominal fat.
  5. Limit alcohol consumption: Aim for a maximum of 1-2 drinks per day, if any.
  6. Don't smoke: If you do smoke, quitting reduces your risk over time.
  7. Consider aspirin: For some individuals at higher risk, daily low-dose aspirin might be recommended (but only after consulting with your practitioner).
  8. Manage chronic conditions: Particularly inflammatory bowel disease and diabetes.

Conclusion: Taking Control of Your Colorectal Cancer Risk

Colorectal cancer is largely preventable through a combination of lifestyle choices and regular screening. By understanding your personal risk factors and taking proactive steps towards prevention, you can significantly reduce your chances of developing this disease.

The emergence of blood-based screening tests like our Onco-D-Clare test represents an exciting advancement in our ability to detect colorectal cancer early, when it's most treatable. A blood test for colorectal cancer is a less invasive option that may encourage more people to get screened, potentially saving countless lives.

Remember that colorectal cancer prevention is an ongoing commitment to your health, not a one-time effort. Regular discussions with your practitioner about your risk factors and appropriate screening schedule are essential components of an effective prevention strategy.

By combining the power of lifestyle modifications, regular screening, and emerging technologies like blood-based tests, we can work toward a future where colorectal cancer becomes an increasingly rare disease.

To learn more about our innovative testing process or to inquire about colorectal cancer screening options, please contact us for more information.

The information provided is for general educational purposes and should not replace professional medical advice. 

Videos

Explore our curated collection of videos, providing an in-depth look at our innovative solutions and groundbreaking research.

  • Dr Clayton Bell video cover
    Dr. Clayton Bell, MD | Gathering 2023 Interview

    In this insightful interview from the 2023 RGCC Gathering, Dr. Clayton Bell shares his journey of integrating RGCC technologies into his practice in the U.S.

    With a background in Functional, Environmental, and Integrative Medicine, Dr. Bell reveals how he uses RGCC’s cutting-edge cancer diagnostics and therapies to support his patients’ healing. Watch the full video to learn more.

    Helena Pohlmann video cover
    Helena Pohlmann | Gathering 2023 Interview

    Helena Pöhlmann who specializes in holistic medicine shares how she utilizes RGCC products in her clinic to best support her patients. Watch the video to learn about her experience at the 2023 RGCC Gathering in Switzerland.

    Jenny Hrbacek, RN | About RGCC Testing

    Cancer survivor and RGCC Practitioner, Jenny Hrbaceck, discusses RGCC testing and the impact it has made on her life.

  • Bita Badakhshan
    Bita Badakhshan - RGCC Gathering 2023 Interview

    Watch an interview with Dr. Bita Badakhshan, a seasoned practitioner in primary family medicine with over 12 years of experience in integrative oncology and functional medicine.

    In this video, Dr. Bita shares her experience with RGCC’s transformative liquid biopsy testing. She highlights the unparalleled precision and detail offered by RGCC's advanced methodologies over other laboratories.

    Dr. Bita emphasizes the unmatched sensitivity of RGCC's testing, which delves deep into analyzing stem cells, cancer cells, and a comprehensive array of markers crucial for personalized cancer care.

    Since 2012, Dr. Beta has trusted RGCC for blood testing on patients, particularly focusing on circulating tumor cell analysis and using RGCC’s Oncocount and Oncotrace tests along with the Onconomics Plus assessments.

    Through RGCC's innovative tests and therapies, Dr. Bita has been able to make informed decisions sparing many patients from unnecessary chemotherapy and radiation post-tumor removal surgeries.

    Podcast video cover
    Podcast - Innovation in Early Cancer Detection

    Join host Sam Tejada for an essential conversation about cancer innovation and breakthroughs on this episode of A Healthy Point of View, including a close look at advances in early cancer detection - as early as stage ZERO.

    Tejada sits down with two leading medical experts: Dr. Christopher Davis, an interventional cardiologist and CMO of Liquivida, and Dr. Ioannis Papasotiriou, MD, PhD, SCym, the founder of RGCC.

    Together, they tackle one of medicine's most complex challenges, sharing cutting-edge insights and breakthrough approaches that could transform how we understand and address cancer care.

Videos

Explore our curated collection of videos, providing an in-depth look at our innovative solutions and groundbreaking research.

  • Dr Clayton Bell video cover
    Dr. Clayton Bell, MD | Gathering 2023 Interview

    In this insightful interview from the 2023 RGCC Gathering, Dr. Clayton Bell shares his journey of integrating RGCC technologies into his practice in the U.S.

    With a background in Functional, Environmental, and Integrative Medicine, Dr. Bell reveals how he uses RGCC’s cutting-edge cancer diagnostics and therapies to support his patients’ healing. Watch the full video to learn more.

  • Helena Pohlmann video cover
    Helena Pohlmann | Gathering 2023 Interview

    Helena Pöhlmann who specializes in holistic medicine shares how she utilizes RGCC products in her clinic to best support her patients. Watch the video to learn about her experience at the 2023 RGCC Gathering in Switzerland.

  • Jenny Hrbacek, RN | About RGCC Testing

    Cancer survivor and RGCC Practitioner, Jenny Hrbaceck, discusses RGCC testing and the impact it has made on her life.

  • Bita Badakhshan
    Bita Badakhshan - RGCC Gathering 2023 Interview

    Watch an interview with Dr. Bita Badakhshan, a seasoned practitioner in primary family medicine with over 12 years of experience in integrative oncology and functional medicine.

    In this video, Dr. Bita shares her experience with RGCC’s transformative liquid biopsy testing. She highlights the unparalleled precision and detail offered by RGCC's advanced methodologies over other laboratories.

    Dr. Bita emphasizes the unmatched sensitivity of RGCC's testing, which delves deep into analyzing stem cells, cancer cells, and a comprehensive array of markers crucial for personalized cancer care.

    Since 2012, Dr. Beta has trusted RGCC for blood testing on patients, particularly focusing on circulating tumor cell analysis and using RGCC’s OncoCount and OncoTrace tests along with the Onconomics Plus assessments.

    Through RGCC's innovative tests and therapies, Dr. Bita has been able to make informed decisions sparing many patients from unnecessary chemotherapy and radiation post-tumor removal surgeries.

    Read more about our therapies on our website: https://rgcc-international.com/rgcc-therapies/

    RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.

    Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.

    Learn more about RGCC at
    https://rgcc-international.com/

    Follow us on social media to find out the latest news and updates from our experts.

    Facebook: https://www.facebook.com/profile.php?id=61554630098937

    Instagram: https://www.instagram.com/rgcc_north_america/

    LinkedIn: https://www.linkedin.com/company/r-g-c-c-international-gmbh/

  • Podcast video cover
    Podcast - Innovation in Early Cancer Detection

    Join host Sam Tejada for an essential conversation about cancer innovation and breakthroughs on this episode of A Healthy Point of View, including a close look at advances in early cancer detection - as early as stage ZERO.

    Tejada sits down with two leading medical experts: Dr. Christopher Davis, an interventional cardiologist and CMO of Liquivida, and Dr. Ioannis Papasotiriou, MD, PhD, SCym, the founder of RGCC.

    Together, they tackle one of medicine's most complex challenges, sharing cutting-edge insights and breakthrough approaches that could transform how we understand and address cancer care.

RGCC
Follow Us
RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View Certificate
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
Manufacturing License for Cosmetic Products and Food Supplements under GMP (Good Manufacturing Practices)
Ref. No. 57067
View Details
Hellenic National Organization for Medicines (EOF)
Production License for Investigational ATMPs for Human Use
Ref. No. 7282
View Details
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map
cross